Volume 19 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
ZHU Xin-ying, ZHAO Li-wei, MENG Xia, YANG Liang, JIAO Li, MA Huan. Short-term efficacy of Xiangsha Pingwei Granule in the treatment of Helicobacter pylori gastritis with dyspepsia[J]. Chinese Journal of General Practice, 2021, 19(7): 1107-1110, 1178. doi: 10.16766/j.cnki.issn.1674-4152.001996
Citation: ZHU Xin-ying, ZHAO Li-wei, MENG Xia, YANG Liang, JIAO Li, MA Huan. Short-term efficacy of Xiangsha Pingwei Granule in the treatment of Helicobacter pylori gastritis with dyspepsia[J]. Chinese Journal of General Practice, 2021, 19(7): 1107-1110, 1178. doi: 10.16766/j.cnki.issn.1674-4152.001996

Short-term efficacy of Xiangsha Pingwei Granule in the treatment of Helicobacter pylori gastritis with dyspepsia

doi: 10.16766/j.cnki.issn.1674-4152.001996
Funds:

 20190638

  • Received Date: 2020-09-19
    Available Online: 2022-02-16
  •   Objective  To evaluate the efficacy and safety of Xiangsha Pingwei Granule in the treatment of Helicobacter pylori (H. pylori) gastritis with dyspepsia.  Methods  Total 240 H. pylori gastritis patients with dyspepsia were randomly divided into control group and observation group, 120 cases each. Control group received 220 mg Bismuth Potassium Citrate+Rabeprazole 10 mg+Amoxicillin 1 000 mg+Clarithromycin 500 mg, oral twice a day for 14 days; observation group received Xiangsha Pingwei Granule 10 g twice a day for 14 days based on the control group. H. pylori eradication rate, TCM clinical symptom score, serum pepsinogen (PG)Ⅰ, PGⅡ, pepsinogen ratio (PGR) levels and adverse reactions were compared between the two groups.  Results  There was no significant difference in the eradication rate of H. pylori between the two groups (90.4% vs. 93.8%, χ2=0.890, P=0.345). The total effective rate of observation group was 89.5%, which was significantly higher than 79.5% of the control group (χ2=4.325, P=0.038). The scores of TCM symptoms of the two groups decreased with time. The decrease of the above symptom scores in the observation group was significantly higher than control group. The overall level of the above symptom scores in the observation group was significantly lower than control group. The serum levels of PGⅠ, PGⅡ and PGR in the two groups decreased with time. The decrease of the above indexes in the observation group was significantly greater than control group. The overall level of the above indexes in the observation group was significantly lower than that in the control group. There were 20 cases (17.5%) of adverse reactions in observation group, which was significantly lower than 32 cases (28.6%) in the control group (χ2=3.878, P=0.049).  Conclusion  Xiangsha Pingwei Granule combined with quadruple therapy in the treatment of H. pylori gastritis complicated with dyspepsia has good clinical efficacy and safety, which is worthy of clinical promotion.

     

  • loading
  • [1]
    张声生, 赵鲁卿. 功能性消化不良中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(6): 2595-2598. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201706072.htm
    [2]
    刘宏伟, 黄玉洁, 杨剑英, 等. 铝碳酸镁、兰索拉唑、阿莫西林、呋喃唑酮四联疗法治疗幽门螺杆菌相关性胃溃疡的效果及安全性评价[J]. 中国综合临床, 2020, 36(1): 22-23, 27.
    [3]
    中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组, 全国幽门螺杆菌研究协作组, 刘文忠, 等. 第五次全国幽门螺杆菌感染处理共识报告[J]. 胃肠病学, 2017, 22(6): 346-360. doi: 10.3969/j.issn.1008-7125.2017.06.006
    [4]
    MALFERTHEINER P, MEGRAUD F, O'MORAIN C A, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report[J]. Gut, 2017, 66(1): 6-30. doi: 10.1136/gutjnl-2016-312288
    [5]
    朱新影, 杜娟, 赵文娟, 等. 两种益生菌联合铋剂四联疗法根除幽门螺杆菌疗效分析[J]. 中华医学杂志, 2018, 98(28): 2246-2249. doi: 10.3760/cma.j.issn.0376-2491.2018.28.007
    [6]
    白海燕, 郝旭蕊, 李娜, 等. 化浊解毒方治疗慢性萎缩性胃炎伴幽门螺杆菌感染患者的临床研究[J]. 南京中医药大学学报, 2020, 36(3): 326-330. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202003012.htm
    [7]
    谢伟昌, 李京伟, 刘磊, 等. 健脾和胃方合"标准四联"治疗幽门螺杆菌阳性慢性非萎缩性胃炎患者的疗效评价[J]. 中医药信息, 2020, 37(4): 122-125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN202004028.htm
    [8]
    魏治伟. 香砂六君子汤联合丹参饮加减治疗Hp阳性慢性胃炎疗效观察[J]. 实用临床医药杂志, 2018, 22(19): 67-71. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL201819019.htm
    [9]
    中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年, 上海)[J]. 胃肠病学, 2017, 22(11): 670-687. https://www.cnki.com.cn/Article/CJFDTOTAL-WIEC201711013.htm
    [10]
    中华中医药学会脾胃病分会, 张声生, 唐旭东. 慢性胃炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(7): 3060-3064. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201707063.htm
    [11]
    郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 151-152.
    [12]
    FISCHBACH W, MALFERTHEINER P. Helicobacter Pylori Infection[J]. Dtsch Arztebl Int, 2018, 115(25): 429-436.
    [13]
    卢光荣, 何柏琪, 林颖, 等. 根除幽门螺旋杆菌感染对不同程度胃黏膜肠上皮化生患者病理学改变的前瞻性研究[J]. 中华全科医学, 2019, 17(4): 571-573. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201904015.htm
    [14]
    阿达克·赛肯, 宋志强, 周丽雅. 幽门螺杆菌感染初治患者1440例根除治疗方案的对比研究[J]. 中华消化杂志, 2017, 37(7): 433-437. doi: 10.3760/cma.j.issn.0254-1432.2017.07.001
    [15]
    陈万群, 黄玉兰, 杨小军. 运脾清热除湿方治疗幽门螺杆菌相关性胃炎消化不良的临床观察及可能机制[J]. 湖南中医药大学学报, 2019, 39(5): 635-639. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZX201905018.htm
    [16]
    杨靖, 彭晶晶, 芦夏阳, 等. 苍术的研究进展[J]. 陕西农业科学, 2018, 64(4): 77-80. https://www.cnki.com.cn/Article/CJFDTOTAL-SNKX201804026.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (328) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return